132 related articles for article (PubMed ID: 3513527)
1. Effects of guanfacine on growth hormone, prolactin, renin, lipoproteins and glucose in essential hypertension.
Hauger-Klevene JH; Balossi EC; Scornavacchi JC
Am J Cardiol; 1986 Mar; 57(9):27E-31E. PubMed ID: 3513527
[TBL] [Abstract][Full Text] [Related]
2. Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment.
Hauger-Klevene JH; Balossi EC; Scornavacchi JC
Cor Vasa; 1987; 29(4 Suppl 1):17-22. PubMed ID: 3119290
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and endocrine responses to guanfacine in normotensive volunteers and hypertensive patients.
Rosenthal JH
Am J Cardiol; 1986 Mar; 57(9):22E-26E. PubMed ID: 3513526
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure and prolactin: effects of guanfacine. Three-year follow-up study.
Hauger-Klevene JH; Pinkas MB; Gerber S
Hypertension; 1981; 3(6 Pt 2):II-222-5. PubMed ID: 7028619
[TBL] [Abstract][Full Text] [Related]
5. Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension.
Collart F; Staroukine M; Verniory A
Acta Cardiol; 1985; 40(3):269-76. PubMed ID: 3895792
[TBL] [Abstract][Full Text] [Related]
6. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
Schoeppe W; Brecht HM
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
[TBL] [Abstract][Full Text] [Related]
7. Effect of guanfacine on blood pressure and renin activity in hypertensive patients.
Rosenthal J
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):91S-96S. PubMed ID: 6994787
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
Manhem P; Hökfelt B
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763
[No Abstract] [Full Text] [Related]
9. Evaluation of long-term treatment of essential hypertension with guanfacine.
Higuchi M; Overlack A; Stumpe KO
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
[TBL] [Abstract][Full Text] [Related]
10. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
Rosenthal J; Jäger H
MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
[TBL] [Abstract][Full Text] [Related]
11. Guanfacine in essential hypertension: effects during rest and isometric exercise.
Hedner T; Nyberg G; Mellstrand T
Clin Pharmacol Ther; 1984 May; 35(5):604-9. PubMed ID: 6370553
[TBL] [Abstract][Full Text] [Related]
12. The effect of chronic guanfacine administration on high plasma vasopressin levels in essential hypertension.
Berkman K; Tözün N; Taga Y; Dedeoğlu A; Onat F; Bekiroğlu N
Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):67-71. PubMed ID: 2407671
[TBL] [Abstract][Full Text] [Related]
13. Effects of clonidine and guanfacine in essential hypertension.
Farsang C; Varga K; Vajda L; Alföldi S; Kapocsi J
Clin Pharmacol Ther; 1984 Nov; 36(5):588-94. PubMed ID: 6386275
[TBL] [Abstract][Full Text] [Related]
14. Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
Ikeda T; Gomi T; Yuhara M; Sakurai J; Nakayama D
Clin Pharmacol Ther; 1988 Mar; 43(3):278-82. PubMed ID: 3278821
[TBL] [Abstract][Full Text] [Related]
15. Effects of single and multiple doses of guanfacine in essential hypertension.
Zamboulis C; Reid JL
Clin Pharmacol Ther; 1980 Dec; 28(6):715-21. PubMed ID: 7002428
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of low dose guanfacine, once a day, for 24-hour control of essential hypertension.
Keenan RE; Black PL; Freudenburg JC; Hill JA; Holmburg CE; Reitbrock MJ; Sullivan MJ; Thompson MT; Wright DL
Am J Cardiol; 1986 Mar; 57(9):38E-42E. PubMed ID: 3513529
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamics in hypertensive patients before and during guanfacine treatment.
Schäfer N; Rauh J; Rosenthal J
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate hypertension.
Materson BJ; Kessler WB; Alderman MH; Canosa FL; Finnerty FA; Savran SV; McMillen JI; Marlon AM
Am J Cardiol; 1986 Mar; 57(9):32E-37E. PubMed ID: 3513528
[TBL] [Abstract][Full Text] [Related]
19. An ambulatory trial of guanfacine.
Mann S; Millar Craig MW; Melville DI; Cashman PM; Raftery EB
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):103S-107S. PubMed ID: 6994762
[TBL] [Abstract][Full Text] [Related]
20. Systemic and cardiac haemodynamic interactions between guanfacine and hydrallazine in hypertensive patients.
Velasco M; Urbina-Quintana A; Morillo J; Vizcarrondo H; Ramirez A; Hernández E; Hernández-Pieretti O
Eur J Clin Pharmacol; 1984; 27(4):393-6. PubMed ID: 6394347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
